Global Cancer Pain Therapeutics Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Drug Class;

Opioids, Non-Steroidal Anti-Inflammatory Drugs and Others.

By Route of Administration;

Intravenous, Oral, and Inhalational.

By Distribution Channel;

Hospital pharmacies, Retail pharmacies, and Online pharmacies.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn137051356 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Cancer Pain Therapeutics Market (USD Million), 2021 - 2031

In the year 2024, the Global Cancer Pain Therapeutics Market was valued at USD 7,991.53 million. The size of this market is expected to increase to USD 11,677.66 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.6%.

The global market for cancer pain therapeutics has witnessed significant growth driven by the increasing prevalence of cancer worldwide. Cancer pain, a distressing symptom experienced by a majority of cancer patients, remains a critical focus area for pharmaceutical companies and healthcare providers alike. As the incidence of cancer continues to rise, particularly in aging populations and emerging economies, the demand for effective pain management solutions has escalated correspondingly.

In recent years, advancements in medical research and technology have led to the development of innovative therapies tailored specifically for managing cancer-related pain. These advancements include novel drug formulations, targeted therapies, and multimodal approaches that aim to enhance efficacy while minimizing side effects. Additionally, the growing awareness among healthcare professionals about the importance of pain management in improving patients' quality of life has further spurred market expansion.

The competitive landscape of the cancer pain therapeutics market is characterized by the presence of both established pharmaceutical companies and emerging biotechnology firms. Market players are increasingly focusing on research and development initiatives to introduce new treatment options and improve existing therapies. Moreover, strategic collaborations, mergers, and acquisitions are prevalent strategies adopted by companies to strengthen their market position and expand their product portfolios. As the healthcare industry continues to prioritize personalized medicine and patient-centric care, the outlook for advancements in cancer pain therapeutics remains promising, with a continued emphasis on enhancing treatment outcomes and patient comfort.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Drug Class
    2. Market Snapshot, By Route of Administration
    3. Market Snapshot, By Distribution Channel
    4. Market Snapshot, By Region
  4. Global Cancer Pain Therapeutics Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Aging Population
        2. Increasing Cancer Prevalence
        3. Advancements in Pain Management
      2. Restraints
        1. Side Effects of Therapeutics
        2. Regulatory Challenges
        3. High Cost of Treatment
      3. Opportunities
        1. Novel Therapeutic Approaches
        2. Emerging Markets
        3. Palliative Care Focus
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Cancer Pain Therapeutics Market, By Drug Class, 2021 - 2031 (USD Million)
      1. Opioids
      2. Non-Steroidal Anti-Inflammatory Drugs
      3. Others
    2. Global Cancer Pain Therapeutics Market, By Route of Administration, 2021 - 2031 (USD Million)
      1. Intravenous
      2. Oral
      3. Inhalational
    3. Global Cancer Pain Therapeutics Market, By Distribution Channel, 2021 - 2031 (USD Million)
      1. Hospital pharmacies
      2. Retail pharmacies
      3. Online pharmacies
    4. Global Cancer Pain Therapeutics Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Purdue Pharma
      2. Teva Pharmaceutical Industries Ltd.
      3. Johnson & Johnson
      4. Novartis AG
      5. Pfizer Inc.
      6. Eli Lilly and Company
      7. Abbott Laboratories
      8. Mallinckrodt Pharmaceuticals
      9. Endo Pharmaceuticals
      10. GlaxoSmithKline PLC
  7. Analyst Views
  8. Future Outlook of the Market